losses – Talk Bio

Pharma’s wins and losses in Trump’s sprawling executive order on drug prices

1 week ago talkbio0Tagged drug price, Industry, Insulin, IRA, losses, Mediation, Medicare, Prices, small molecule drugs

Medicare, Medicare, Industry, drug price, Mediation, small molecule drugs, losses, IRA, Insulin, Prices

The 5 Largest Biopharma Layoffs of Q1 2025: An Overview of Industry Restructuring

2 weeks ago talkbio0Tagged 2025, Biopharma layoffs, Drug Industry, Galapagos layoffs, Gilead, Industry, losses, Merck, Myers, Novartis, Q1 2025, restructuring, Squibb Layoffs, trends qualifier

Biopharma layoffs 2025, Novartis layoffs, Galapagos layoffs, Bristol Myers Squibb layoffs, Merck cuts, Gilead workforce reduction, Q1 2025 job cuts, biotech restructuring, pharmaceutical industry job losses, industry trends.

Sanofi Workers Strike Over Consumer Health Unit Sale Amid Job Loss and Strategic Asset Concerns

6 months ago talkbio0Tagged Clayton, consumer health unit, DOLIPRANE, France, losses, Opella, Sales - occupational activity, sanofi, strategic assets

Sanofi, strike, consumer health unit, sale, job losses, strategic assets, France, Doliprane, Opella, Clayton Dubilier & Rice

GSK to Close UK Antibiotic Factory in Ulverston Following Sandoz Contract Termination

8 months ago talkbio0Tagged Antibiotic Factory, Contract agreement, losses, Reparative closure, sandoz, SmithKline Beecham, Ulverston

GSK, Ulverston, antibiotic factory, Sandoz contract, closure, job losses